Shayna Chotai
@ShaynaChotai
Followers
99
Following
150
Media
0
Statuses
19
Cardiology Registrar | NIHR Doctoral Fellow | Imperial College London
Joined December 2012
TikTok talks - 5 minute presentations on recent studies and trials each followed by discussion times - what a great idea to get the updates on trials and studies in INOCA! Cmd-CHAMP, PRIZE, AID ANGIO, WARRIOR 😃 @MillbrookMed @AishSinha1 @divaka_perera @InocaInternati1
0
5
8
Our review discusses lessons learnt from ORBITA and ORBITA-2 and highlights the next key questions @rallamee @fiyyazAJ @MikeFoley89
https://t.co/9Bn2G9j649
0
0
8
From CAD to atherosclerotic coronary artery disease? @TheLancet Commission led by @rallamee includes @DFCapodanno @EuroInterventio Editor-in-Chief , @mirvatalasnag PCRonline Editorial Board member, @NievesGonzalo1 #EuroPCR Course Director, and @nickaram PCR Innovators Day
Our Commission, now published in The Lancet, advocates redefining coronary artery disease as atherosclerotic coronary artery disease (ACAD). This shift moves beyond the traditional ischemia-centered model to a systematic approach addressing atherosclerosis earlier. We believe
0
8
25
Two new NovPods! Episode 8 @damien_hug261 talks us through pain management in labour. Episode 9 Who knows most about obstetric anaesthetic drugs? @DoreEoin & Dr Rahul Bandopadhyay go head to head. 🎧 https://t.co/xYQ2W9b2xj
#AnaesthesiaOnAir
0
7
13
#SimPub #CIrcTCT24 In the ORBITA-2 trial, severity of coronary stenosis (FFR/iFR) was predictive of anginal benefit in this placebo (sham procedure) controlled trial https://t.co/LjkdRE0I7x
1
9
24
It was such a pleasure to join @rallamee to talk all things ESC 2024 Thank you so much @TheLancet #chloewilson
https://t.co/fyKYOasxo1
open.spotify.com
The Lancet in conversation with · Episode
0
3
19
Just in case you thought the ORBITA team had gone on summer vacation… The first ORBITA-MOON case was completed yesterday. Another n-of-1 trial that might have some interesting results. Well done @ShaynaChotai on achieving the first of many big milestones during your PhD!
2
12
139
The symptom stratified analysis of ORBITA2 and the ORBITA-STAR trial both presented at #EuroPCR2024 and simultaneously published in @JACCJournals by @FloSimader and @rajkumar_chris. PCI isn’t a therapy for all symptoms, it’s a therapy for angina @rallamee @mshunshin
0
19
56
#EuroPCR #JACC LBCT SimPub: #ORBITA-2 symptom-stratified analysis - Although symptom severity & nature were poorly associated with disease severity, the nature of symptoms powerfully predicted the placebo-controlled efficacy of #PCI. https://t.co/gTBH37zmyo
@FloSimader @rallamee
1
11
37
How do you evaluate persistent symptoms after a #PCI procedure? At #EuroPCR, Dr. @rajkumar_chris from #ORBITA demonstrates that when symptoms map to a stenosis, PCI is effective. Check out the full results in #JACC: https://t.co/DSpWm9dLu5
@rallamee
4
8
34
Goodbye #ACC from the ORBITA team. Thank you for featuring our work and see you again next year! @FloSimader @ShaynaChotai @MikeFoley89 @rajkumar_chris @fiyyazAJ @mshunshin
3
7
134
Amazing to see a brilliant friend and colleague @MikeFoley89 present the #ORBITA-COSMIC trial of the coronary sinus reducer with simultaneous publication in @TheLancet @rallamee @ImperialNHLI @ImperialNHS #ACC2024
https://t.co/zzFSIYlhbz
1
14
69
Here we go again! Want to see if the coronary sinus reducer works in refractory angina? Watch @MikeFoley89 present the results of the ORBITA-COSMIC in the main arena at #ACC this Monday #ORBITA @fiyyazAJ @mshunshin @ShaynaChotai @rajkumar_chris @FloSimader
4
39
163
Incredibly proud to celebrate @rallamee being awarded the Global CV Future Leader Award 2024 #GCVAwards. An exceptional mentor to us, who has also built a strong team of young researchers at Imperial College @mshunshin @rajkumar_chris @MikeFoley89 @FloSimader @ShaynaChotai
3
3
47
I’m delighted to see our paper highlighted by TCT MD. Our belief in a therapy is associated with how intuitive it seems. This may subconsciously influence the threshold we set for randomised data. We should keep this in mind as we appraise procedures, new and old. @rallamee
Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective
1
5
17
2. NovPod is a light-hearted informative intro to the specialty and an audio companion to the Novice Guide. Brought to you by creators and hosts @DoreEoin and Dr Duncan Kemp. https://t.co/Evr6fYweoj
1
2
6